Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and α 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat
暂无分享,去创建一个
E. Conway | A. Gundlach | A. L Gundlach | E. L Conway | J. A Craven | J. Craven | A. L. Gundlach | E.L Conway | J.A Craven
[1] Andrew L. Gundlach,et al. Quantitative autoradiographic localization in rat brain of α 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine , 1995, Brain Research.
[2] K. Hossmann,et al. Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia , 1990, Neuroscience.
[3] D. Bylund,et al. α 2-agonist binding sites in brain: [125I]Para-iodoclonidine versus [3H]para-aminoclonidine , 1993, Brain Research Bulletin.
[4] A. Miralles,et al. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. , 1993, The Journal of pharmacology and experimental therapeutics.
[5] C. Petito,et al. The Two Patterns of Reactive Astrocytosis in Postischemic Rat Brain , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] D. Reis,et al. Expression of non‐adrenergic imidazoline sites in rat cerebral cortical astrocytes , 1993, Journal of neuroscience research.
[7] Richard S. J. Frackowiak,et al. Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] F. Tesson,et al. Localization of I2-Imidazoline Binding Sites on Monoamine Oxidases (*) , 1995, The Journal of Biological Chemistry.
[9] P. R. King,et al. α2-adrenoceptor and catecholamine-insensitive binding sites for [3H]rilmenidine in membranes from rat cerebral cortex , 1992 .
[10] T. Halonen,et al. α2-Adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage , 1995, Brain Research.
[11] J. Bénavidès,et al. Cellular distribution of ω 3 (peripheral type benzodiazepine) binding sites in the normal and ischaemic rat brain: An autoradiographic study with the photoaffinity ligand [3H]PK 14105 , 1990, Neuroscience Letters.
[12] A. Gundlach,et al. Differential Regulation of Angiotensinogen and Natriuretic Peptide mRNAs in Rat Brain by Osmotic Stimulation: Focus on Anterior Hypothalamus and Supraoptic Nucleus , 1997, Peptides.
[13] P. Escribá,et al. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain , 1994, British journal of pharmacology.
[14] F. Leslie,et al. Further pharmacological characterization of [3H]idazoxan binding sites in rat brain: evidence for predominant labeling ofα 2-adrenergic receptors , 1992, Brain Research.
[15] E. J. Green,et al. Effect of Delayed MK-801 (Dizocilpine) Treatment with or without Immediate Postischemic Hypothermia on Chronic Neuronal Survival after Global Forebrain Ischemia in Rats , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] O. Steward,et al. The Process of Reinnervation in the Dentate Gyrus of Adult Rats: Temporal Relationship between Changes in the Levels of Glial Fibrillary Acidic Protein (GFAP) and GFAP mRNA in Reactive Astrocytes , 1993, Experimental Neurology.
[17] J. García-Sevilla,et al. Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease , 1993, Neuroscience Letters.
[18] P. Escribá,et al. LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration. , 1995, European journal of pharmacology.
[19] A. Basbaum,et al. Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution , 1987, Brain Research Bulletin.
[20] D. Nutt,et al. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. , 1996, European journal of pharmacology.
[21] W. Dunlap,et al. Selective Vulnerability and Early Progression of Hippocampal CA1 Pyramidal Cell Degeneration and GFAP-Positive Astrocyte Reactivity in the Rat Four-Vessel Occlusion Model of Transient Global Ischemia , 1993, Experimental Neurology.
[22] D. Reis,et al. Reduction in Focal Cerebral Ischemia by Agents Acting at Imidazole Receptors , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] D. Duverger,et al. Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of neuroprotective drugs , 1991, Brain Research.
[24] M. Sastre,et al. Opposite Age‐Dependent Changes of α2A‐Adrenoceptors and Nonadrenoceptor [3H]Idazoxan Binding Sites (I2‐Imidazoline Sites) in the Human Brain: Strong Correlation of I2 with Monoamine Oxidase‐B Sites , 1993, Journal of neurochemistry.
[25] Y. Nakashima,et al. Differential Changes in α- and β-Adrenoceptors in the Cerebral Cortex and Hippocampus of the Mongolian Gerbil After Unilateral Brain Ischemia , 1995 .
[26] R. Schmidt-Kastner,et al. Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.
[27] Stanley J. Watson,et al. The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.
[28] F. Gonon,et al. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. , 1991, European journal of pharmacology.
[29] E. Mackenzie,et al. The pharmacotherapy of focal cortical ischaemia in the mouse , 1990, Brain Research.
[30] T. Wieloch,et al. Protection against Ischemia-Induced Neuronal Damage by the α2-Adrenoceptor Antagonist Idazoxan: Influence of Time of Administration and Possible Mechanisms of Action , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] C. Petito,et al. Delayed Neuronal Recovery and Neuronal Death in Rat Hippocampus following Severe Cerebral Ischemia: Possible Relationship to Abnormalities in Neuronal Processes , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] M. Maze,et al. Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. , 1993, Anesthesiology.
[33] N. French. Alpha 2-adrenoceptors and I2 sites in the mammalian central nervous system. , 1995, Pharmacology & therapeutics.
[34] W. Hoffman,et al. Clonidine Decreases Plasma Catecholamines and Improves Outcome From Incomplete Ischemia in the Rat , 1991, Anesthesia and analgesia.
[35] J. van Reempts,et al. Histopathological characterization of photochemical damage in nervous tissue. , 1994, Histology and histopathology.
[36] R. Busto,et al. Direct Evidence for Acute and Massive Norepinephrine Release in the Hippocampus during Transient Ischemia , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[37] A. Parini,et al. The elusive family of imidazoline binding sites. , 1996, Trends in pharmacological sciences.
[38] J. Brierley,et al. The origin of lipid phagocytes in the central nervous system: I. The intrinsic microglia , 1982, The Journal of comparative neurology.
[39] K. Hossmann,et al. Immunocytochemical Study of an Early Microglial Activation in Ischemia , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] D. Reis,et al. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. , 1991, European journal of pharmacology.
[41] Y. Uchiyama,et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] Fred Plum,et al. Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.
[43] J. Brierley,et al. A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat , 1979, Stroke.
[44] M. Dontenwill,et al. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. , 1989, European journal of pharmacology.
[45] A. Hudson,et al. Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain , 1992, British journal of pharmacology.
[46] Michel Baudry,et al. Systemic injection of kainic acid: Gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography , 1990, Experimental Neurology.
[47] D. Duverger,et al. The quantification of brain lesions with anω 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration , 1990, Brain Research.
[48] T. Wieloch,et al. Postischemic Administration of Idazoxan, an α-2 Adrenergic Receptor Antagonist, Decreases Neuronal Damage in the Rat Brain , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[49] M. Dontenwill,et al. Rilmenidine selectivity for imidazoline receptors in human brain. , 1989, European journal of pharmacology.
[50] W. Streit,et al. The Microglial Reaction in the Rat Dorsal Hippocampus following Transient Forebrain Ischemia , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] D. Nutt,et al. Functional Studies of Specific Imidazoline‐2 Receptor Ligands , 1995, Annals of the New York Academy of Sciences.
[52] D. Reis,et al. Imidazoline receptors and their endogenous ligands. , 1996, Annual review of pharmacology and toxicology.
[53] P. R. King,et al. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites Studies in rabbit kidney membranes , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[54] O. Lindvall,et al. Lesions of the locus coeruleus system aggravate ischemic damage in the rat brain , 1985, Neuroscience Letters.
[55] T. Wieloch,et al. Effects of ischemia on regional ligand binding to adrenoceptors in the rat brain , 1992, Journal of the Neurological Sciences.
[56] M. Kindy,et al. Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. , 1992, Brain research. Molecular brain research.
[57] W. Hoffman,et al. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. , 1991, Anesthesiology.
[58] M. Graeber,et al. Functional plasticity of microglia: A review , 1988, Glia.
[59] M. Kuhar,et al. Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.
[60] D. Schober,et al. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[61] P. Skolnick,et al. Subcellular Localization of “Peripheral‐Type” Binding Sites for Benzodiazepines in Rat Brain , 1986, Journal of neurochemistry.